Viatris said on Friday that its experimental eye ointment failed to clear buildup or debris in the eyes in a late-stage study in patients with an inflammatory eye condition.

Viatris said on Friday that its experimental ophthalmic ointment failed to meet the main goal of a late-stage study in patients with an eye condition that causes inflammation.

Viatris's said on Friday that the trial of an ointment for people with blepharitis didn't meet its primary endpoint.

Viatris’ investigational blepharitis ointment failed to achieve the primary endpoint in its Phase III trial, prompting the ...

The symptoms of dry eye are multifactorial, says Mina Massaro-Giordano, MD, making identifying and treating dry eye important ...

The Supreme Court on Friday upheld a provision of the Affordable Care Act that requires insurance companies to offer some kinds of preventive care for free. In a 6-to-3 decision, written by ...

Reflecting ongoing concerns around drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control Organisation (CDSCO) has flagged 130 drug samples as Not ...

US-Israeli aid distributor the Gaza Humanitarian Foundation has been widely condemned for possible complicity in war crimes ...

Spain's SpliceBio has raised $135m in financing that will help it move a gene-editing therapy for Stargardt disease through clinical testing.

Object Details Associated Name Sherman Pharmacy maker William H. Rorer, Inc. Description The indications or uses for this product as provided by the manufacturer are: For skin irritations, burns and ...

Best for before bed: Hycosan Night Eye Ointment - £7.49, Amazon Best for optician recommended: Hycosan and Optase Dry Eye Kit - £27.50, Feel Good Contacts ...